Monday, 31 August 2026European Markets

AUREA Stock Bullish Momentum With A 14.07% Rise Before The Weekend

Loading stream...

(vianews) - the market ended the session with aurea (aure.pa) rising 14.07% to €6.00 on friday, following the last session's upward trend. cac 40 fell 0.56% to €7,628.57, following the last session's upward trend on what was a somewhat down trend trading session today.

about aurea

aurea sa engages in the recycling of black motor oil in france. the company is also involved in the manufacturing of remold tires from used tires and recycling rigid pvc. it recycles plastics and packaging products; refines and recycles aluminum; recycles copper and produces copper alloys; and treats and recycles zinc, lead, and cadmium. in addition, the comany engages in the treatment and decontamination of mercury waste. the company was formerly known as auer and changed its name to aurea sa in 1988. aurea sa is based in paris, france.

earnings per share

as for profitability, aurea has a trailing twelve months eps of €0.49.

pe ratio

aurea has a trailing twelve months price to earnings ratio of 12.24. meaning, the purchaser of the share is investing €12.24 for every euro of annual earnings.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, aurea's stock is considered to be oversold (<=20).

more news about aurea (aure.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com